Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport Injection for Chronic Lateral Epicondylitis
NCT00497913Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2007
- Primary completion
- Mar 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in Lateral Epicondylitis (LET), sponsored by Tehran University of Medical Sciences. Started Aug 2007; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT00497913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00497913.